Picture of Aktis Oncology logo

AKTS — Aktis Oncology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapSucker Stock

Brief: Akoustis Receives Development Order For Two New Diplexers From Fortune 100 Internet Company

Aug 24 (Reuters) - Akoustis Technologies Inc  AKTS.O :
    * AKOUSTIS RECEIVES DEVELOPMENT ORDER FOR TWO NEW DIPLEXERS
FROM
FORTUNE 100 INTERNET COMPANY
    * AKOUSTIS TECHNOLOGIES INC - PRE-PRODUCTION PRODUCTS
EXPECTED IN
SECOND HALF OF CALENDAR 2023, PRODUCTION EXPECTED IN FIRST HALF
OF CALENDAR 2024
    * AKOUSTIS - ANNOUNCED IT HAS RECEIVED DEVELOPMENT ORDER
FROM
FORTUNE 100 INTERNET COMPANY FOR TWO NEW XBAW DRIVEN DIPLEXERS
FOR MULTIPLE APPLICATIONS

Source text for Eikon:  ID:nGNX3s2FBz 
Further company coverage:  AKTS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aktis Oncology

See all news